V Light vs Aqualyx vs Kybella: Deoxycholic Acid Lipolytics Compared

V Light Solution, Aqualyx and Kybella all use deoxycholic acid (DCA) to destroy fat cells. They differ in three ways that matter in clinic: concentration, formulation and how much evidence sits behind them. Kybella is 1% DCA, Aqualyx is 0.75% and V Light is 0.5%.
V Light Solution is a 0.5% deoxycholic acid lipolytic injection for facial and localised body fat, distributed in India by NW Aesthetics.
The three products side by side
V Light Solution | Aqualyx | Kybella | |
Active | Deoxycholic acid | Sodium deoxycholate (modified bile acid) | Synthetic deoxycholic acid |
Concentration | 0.5% | 0.75% | 1% (10 mg/ml) |
Other ingredients | Fucus vesiculosus, Juglans regia, Aesculus hippocastanum, tyrosine, disodium adenosine phosphate | Agarose micro-gel, lactose-based carrier, buffer, sodium chloride | Benzyl alcohol, phosphate buffer, sodium chloride |
Pack | 10 vials × 2 ml | 8 ml vial | 4 vials × 2 ml |
Labelled areas | Face and body | Localised fat, face and body | Submental fat only (FDA) |
Evidence | Manufacturer data; no large published trials | Smaller studies and long clinical use in Europe | Two phase 3 trials, over 1,000 patients |
Why concentration matters
DCA is a detergent. It breaks fat cell membranes, but it is not selective for fat. If it reaches nerves, vessels or skin, it damages them too. Higher concentration means more cytolysis per injection point, and more inflammation to manage.
Kybella's phase 3 data shows the trade-off. In REFINE-1, nodules occurred in 12.5% of treated patients vs 0.8% on placebo, and marginal mandibular nerve paresis in 4.3%, mostly mild and transient.
A lower concentration gives finer control in small facial fat pads, where a little too much product in the wrong place shows. No head-to-head trial has compared 0.5% and 1% DCA, so treat this as a clinical rationale, not a proven safety advantage.
Dosing compared
V Light Solution | Kybella | |
Volume per point | 0.1–0.2 ml (never above 0.2 ml) | 0.2 ml, 1 cm apart |
Double chin per session | About 4 ml | Up to 10 ml (50 injections) |
Sessions | 2–3 | Up to 6 |
Interval | 21 days | At least 1 month |
Kybella figures are from its prescribing information. V Light figures are from the manufacturer's dosage protocol. Aqualyx is dosed per its own training protocol.
Which one fits your clinic
Kybella if you only treat double chins and want the most-studied product. Expect higher cost and import supply.
Aqualyx if you mainly treat larger body areas and are trained in its technique.
V Light Solution if you want one product for face and body, a lower concentration for delicate facial zones, and 2 ml vials that match single-area sessions.
FAQ
Is V Light the same as Kybella? No. Both use deoxycholic acid, but V Light is 0.5% with added botanical and metabolic ingredients. Kybella is 1% DCA alone.
Does a lower concentration mean weaker results? Not necessarily, but no trial has compared them directly. Lower concentration products are usually given over a planned course of sessions.
Can V Light be used outside the chin? Yes. Its protocol covers double chin, nasolabial fat, eye bags, arms and abdomen. Kybella is approved for the submental area only.
Is Kybella available in India? It is sold in India through pharmaceutical import suppliers.
Planning a double chin course? Read our double chin lipolysis protocol.
For V Light Solution pricing, training and supply, contact NW Aesthetics.
Disclaimer: This article is for informational purposes for medical professionals and does not replace clinical judgement or the product's instructions for use.
Sources
REFINE-1 phase 3 trial of ATX-101 (deoxycholic acid), Dermatol Surg 2016
Advances in minimally invasive and noninvasive treatments for submental fat, Cutis 2017
Kybella dosing and administration (prescribing information summary)
Aqualyx: 0.75% active deoxycholic acid in a micro-gelatinous solution (Prof. Motolese presentation)
Aqualyx 8 ml vial: CE-marked injectable for localised fat (Consentz)



Comments